Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.

about

Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington's Disease.

P2860

Q55295842-5A2AC920-561B-4999-9F26-6B2EC6D3AA7C

P2860

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.

Item

http://www.wikidata.org/entity/Q42621277

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Neurofilament light protein in ...... untington's disease R6/2 mice.

@en

Neurofilament light protein in ...... untington's disease R6/2 mice.

@nl

type

Item

label

Neurofilament light protein in ...... untington's disease R6/2 mice.

@en

Neurofilament light protein in ...... untington's disease R6/2 mice.

@nl

prefLabel

Neurofilament light protein in ...... untington's disease R6/2 mice.

@en

Neurofilament light protein in ...... untington's disease R6/2 mice.

@nl

P1476

Neurofilament light protein in ...... untington's disease R6/2 mice.

@en

P2093

Maria Björkqvist

http://www.w3.org/2001/XMLSchema#string

Marie Sjögren

http://www.w3.org/2001/XMLSchema#string

Rana Soylu-Kucharz

http://www.w3.org/2001/XMLSchema#string

Åsa Sandelius

http://www.w3.org/2001/XMLSchema#string

P2860

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study.

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.

P2888

s41598-017-14179-1

P304

14114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-14179-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Edward Wild

Kaj Blennow

Henrik Zetterberg

P577

2017-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092349781

http://www.w3.org/2001/XMLSchema#string

P698

29074982

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

5658344

http://www.w3.org/2001/XMLSchema#string

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.

about

P2860

P2860

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932